A report that plasma FSTL1 levels were correlated with hsCRP and ROMs in healthy Japanese male subjects suggests that FSTL1 may be a biomarker of metabolic dysfunction and cardiovascular disease [9]. Here, FSTL1 is linked to cardiovascular disorder.